Challenges of Drug Development in Progressive Multiple Sclerosis

 

In a peer reviewed International Pharmaceutical Industry article, Tomislav Babic, M.D., Ph.D., discusses biomarkers, clinical outcome measures, study design and more for progressive multiple sclerosis.

Questions regarding your upcoming clinical trial?